Tom 12, Nr 3 (2017)
UCZYMY SIĘ!
Opublikowany online: 2017-08-02

dostęp otwarty

Wyświetlenia strony 399
Wyświetlenia/pobrania artykułu 4446
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Alternatywne przyczyny niedokrwienia miokardium u kobiet

Martyna Zaleska1, Olga Możeńska1, Jacek Bil2
Kardiol Inwazyjna 2017;12(3):39-46.

Streszczenie

Choroba niedokrwienna serca pozostaje główną przyczyną zgonów w krajach rozwiniętych. Większość przypadków spowodowana jest miażdżycą tętnic wieńcowych. Jednakże, zwłaszcza w grupie młodszych pacjentów i kobiet, należy brać pod uwagę alternatywne przyczyny niedokrwienia miokardium, takie jak zaburzenia w mikrokrążeniu wieńcowym, samoistne rozwarstwienie tętnicy wieńcowej, czy też dławica naczynioskurczowa. W niniejszej pracy skupiono się na podstawach patofizjologicznych, diagnostyce, objawach, odmiennościach w terapii i rokowaniu pacjentów z niedokrwieniem mięśnia sercowego powodowanym wymienionymi zaburzeniami funkcjonalnymi i strukturalnymi.

Referencje

  1. Mendis S, Davis S, Norrving Bo. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015; 46(5): e121–e122.
  2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385(9963): 117–171.
  3. Vaccarino V. Ischemic heart disease in women: many questions, few facts. Circ Cardiovasc Qual Outcomes. 2010; 3(2): 111–115.
  4. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005; 308(5728): 1583–1587.
  5. Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2009; 158(4): 688–694.
  6. Ahmed B, Creager MA. Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunction. Vasc Med. 2017; 22(2): 146–160.
  7. Arbogast R, Bourassa M. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. The American Journal of Cardiology. 1973; 32(3): 257–263.
  8. Sattar A, Mondragon J, Clegg S, et al. Prevalence and predictors of coronary microvascular dysfunction among patients with ischemia and non-obstructive CAD. J Am Coll Cardiol. 2016; 67(13): 268.
  9. Sara JD, Widmer RJ, Matsuzawa Y, et al. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. JACC Cardiovasc Interv. 2015; 8(11): 1445–1453.
  10. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation. 1984; 69(1): 1–7.
  11. Motz W, Vogt M, Rabenau O, et al. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol. 1991; 68(10): 996–1003.
  12. Agewall S, Beltrame JF, Reynolds HR, et al. WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017; 38(3): 143–153.
  13. Gibson CM, de Lemos JA JA, Murphy SA, et al. Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. J Thromb Thrombolysis. 2002; 14(3): 233–237.
  14. Bailey AL, Smyth SS. Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women. JACC Cardiovasc Interv. 2012; 5(6): 654–655.
  15. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003; 107(25): 3129–3132.
  16. Lanza GA, Colonna G, Pasceri V, et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999; 84(7): 854–86, A8.
  17. Cannon R, Watson R, Rosing D, et al. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. The American Journal of Cardiology. 1985; 56(4): 242–246.
  18. Mehta PK, Goykhman P, Thomson LEJ, et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging. 2011; 4(5): 514–522.
  19. Pepine C, Anderson R, Sharaf B, et al. Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia. Journal of the American College of Cardiology. 2010; 55(25): 2825–2832.
  20. Mering GO, Arant CB, Wessel TR, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004; 109(6): 722–725.
  21. Saw J. Spontaneous coronary artery dissection. Can J Cardiol. 2013; 29(9): 1027–1033.
  22. Nishiguchi T, Tanaka A, Ozaki Y, et al. Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2016; 5(3): 263–270.
  23. Nakashima T, Noguchi T, Haruta S, et al. Prognostic impact of spontaneous coronary artery dissection in young female patients with acute myocardial infarction: A report from the Angina Pectoris-Myocardial Infarction Multicenter Investigators in Japan. Int J Cardiol. 2016; 207: 341–348.
  24. Elkayam U, Jalnapurkar S, Barakkat MN, et al. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014; 129(16): 1695–1702.
  25. Saw J, Mancini GB, Humphries KH. Contemporary Review on Spontaneous Coronary Artery Dissection. J Am Coll Cardiol. 2016; 68(3): 297–312.
  26. Alfonso F, Paulo M, Gonzalo N, et al. Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol. 2012; 59(12): 1073–1079.
  27. Saw J, Aymong E, Sedlak T, et al. Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv. 2014; 7(5): 645–655.
  28. Choi JW, Davidson CJ. Spontaneous multivessel coronary artery dissection in a long-distance runner successfully treated with oral antiplatelet therapy. J Invasive Cardiol. 2002; 14(11): 675–678.
  29. Lettieri C, Zavalloni D, Rossini R, et al. Management and Long-Term Prognosis of Spontaneous Coronary Artery Dissection. Am J Cardiol. 2015; 116(1): 66–73.
  30. Prinzmetal M, Kennamer R, Merliss R, et al. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959; 27: 375–388.
  31. Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation. 2011; 124(16): 1774–1782.
  32. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J. 2000; 64(1): 1–12.
  33. Ogawa H, Yasue H, Oshima S, et al. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation. 1989; 80(6): 1617–1626.
  34. Nakamura Y, Shinozaki N, Hirasawa M, et al. Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Jpn Circ J. 2000; 64(4): 239–242.
  35. Oksuz F, Sensoy B, Sen F, et al. 'Action potential-like' ST elevation following pseudo-Wellens' electrocardiogram. Indian Heart J. 2015; 67(5): 472–475.
  36. Yasue H, Nakagawa H, Itoh T, et al. Coronary artery spasm - clinical features, diagnosis, pathogenesis, and treatment. J Cardiol. 2008; 51(1): 2–17.
  37. Beltrame JF, Crea F, Kaski JC, et al. Coronary Vasomotion Disorders International Study Group (COVADIS). International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2015 [Epub ahead of print].
  38. Fox K, Garcia MA, Ardissino D, et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology, ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006; 27(11): 1341–1381.
  39. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43(2): 109–142.
  40. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988; 78(1): 1–9.
  41. Nohria A, Prsic A, Liu PY, et al. Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis. 2009; 205(2): 517–521.
  42. Gaspardone A, Tomai F, Versaci F, et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol. 1999; 84(1): 96–8, A8.
  43. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007; 356(8): 830–840.